Thomas E. Witzig, Michael B. Tomblyn, Jamal G. Misleh, Ebenezer A. Kio, Robert M. Sharkey, William A. Wegener, and David M. Goldenberg. 2014. “Anti-CD22 90Y-Epratuzumab Tetraxetan Combined With Anti-CD20 Veltuzumab: a Phase I Study in Patients With relapsed/Refractory, Aggressive Non-Hodgkin Lymphoma”. Haematologica 99 (11). Pavia, Italy, 1738-45. https://doi.org/10.3324/haematol.2014.112110.